Search for content, post, videos

Oncopeptides receives a research grant from Vinnova

Oncopeptides has received a research grant of 3 million SEK from Sweden's Innovation Agency (Vinnova), to explore the development of new treatment options for glioblastoma, an aggressive and incurable form of brain cancer. The grant enables exploratory research to better understand the potential
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.